This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cytori Therapeutics Inc (CYTX)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 14.62M 15.51M 25.72M 36.92M
Receivables 1.36M 4.15M 3.93M 2.26M
Inventories 4.83M 3.69M 3.18M 3.32M
Other Current Assets 0.00 1.22M 1.16M 837.00K
Total Current Assets 21.69M 24.58M 33.98M 43.34M
Property, Plant & Equipment, Gross 10.95M 10.60M 10.78M 9.70M
Accumulated Depreciation & Depletion 9.37M 9.55M 8.61M 7.99M
Property, Plant & Equipment, Net 1.58M 1.05M 2.17M 1.71M
Intangibles 9.42M 9.34M 0.00 192.00K
Other Non-Current Assets 2.11M 3.16M 3.18M 2.37M
Total Non-Current Assets 17.03M 17.48M 9.27M 8.20M
Liabilities & Shareholder Equity
Total Assets 38.72M 42.06M 43.25M 51.53M
Accounts Payable 949.00K 965.00K 1.58M 272.00K
Short Term Debt 7.36M 3.19M 9.78M 2.49M
Other Current Liabilities 3.01M 5.64M 418.00K 0.00
Total Current Liabilities 15.92M 14.91M 17.61M 7.82M
Long Term Debt 18.04M 23.10M 12.90M 21.96M
Deferred Income Taxes 558.00K 710.00K 0.00 0.00
Other Non-Current Liabilities 9.90M 212.00K 6.28M 11.80M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 28.50M 24.02M 19.18M 33.77M
Total Liabilities 44.42M 38.93M 36.80M 41.59M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity -5.70M 3.13M 6.46M 9.95M
Common Par 99.00K 71.00K 66.00K 57.00K
Additional Paid In Capital 331.77M 303.71M 281.12M 252.34M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -338.27M -300.90M -274.73M -242.45M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 700.00K 256.00K 0.00 0.00
Total Capitalization 12.34M 26.23M 19.36M 31.91M
Total Equity -5.70M 3.13M 6.46M 9.95M
Total Liabilities & Stock Equity 38.72M 42.06M 43.25M 51.53M
Total Common Shares Outstanding 99.35M 71.31M 65.91M 56.59M
Preferred Shares 325.00 325.00 325.00 325.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 80.83M 67.78M 58.68M 53.50M
Diluted Weighted Shares Outstanding 80.83M 67.78M 58.68M 53.50M
Number of Employees 78 115 127 128
Number of Part-Time Employees 0 0 0 0

CYTX Cytori Therapeutics Inc

Chart of CYTX

Analysts Ratings for CYTX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

CYTX Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs